David Moatazedi Net Worth & Insider Trades

David Moatazedi - See Remarks, Evolus, Inc

As of May 18, 2022

What is David Moatazedi's Net Worth?

The current estimated net worth of Evolus, Inc's See Remarks, David Moatazedi, is estimated to be about $3.07M . David Moatazedi owns about 491,961 units of Evolus, Inc common stock. In the last 4 years at Evolus, Inc, David Moatazedi has sold an estimated value of $2.04M worth.

What is David Moatazedi's Past Insider Trading?

David Moatazedi's largest purchase order was 41,763 units , worth over $466.84K on August 12, 2021. David Moatazedi's largest sale order was 70,445 units , worth over $783.81K on August 17, 2021. In total, David Moatazedi has made about 13 transactions over 4 years of their time at Evolus, Inc. David Moatazedi usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 55,321 units , worth over $754.31K on May 18, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was David Moatazedi's Salary in 2020?

As See Remarks of Evolus, Inc, David Moatazedi has a total base salary of $527,083 . David Moatazedi received compensation valued at about $4,023,245 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of stock awards of $1,232,293 , option awards of $815,869 , other earnings, plans or compensations of $720,500 , and other compensation of $7,000 .

What is David Moatazedi's' Mailing Address?

  • Mailing address is C/o Obalon Therapeutics, Inc. 5421 Avenida Encinas, Suite F Carlsbad CA 92008 CA

Evolus, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Moatazedi 2020 $527,083 - $1,232,293 $815,869 $720,500 $7,000 $4,023,245
David Moatazedi 2019 $550,000 - - $1,169,813 $555,500 $3,500 $2,278,813
Lauren Silvernail 2020 $407,292 - $423,340 $258,714 $222,700 $3,188 $1,315,234
Lauren Silvernail 2019 $425,000 - - $421,133 $171,700 $3,500 $1,021,333
Rui Avelar, M.D. 2020 $403,333 - $423,340 $258,714 $222,576 $5,348 $1,313,311
Rui Avelar, M.D. 2019 $400,000 - - $561,510 $861,600 $13,500 $1,836,610
Michael Jafar 2020 $342,292 - $573,360 $411,994 $226,475 $2,588 $1,556,709
Michael Jafar 2019 $345,000 - - $421,133 $139,380 - $905,513
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1570562/000157056221000128/eols2020proxy.htm

What are Evolus, Inc's Past Insider Trades?

Evolus, Inc's most recent insider trade came on September 16, 2022 by Medytox Inc who sold 97,000 units worth $1M . In the last 4 years, insiders at Evolus, Inc have sold an estimated value of $186.02M and bought an estimated value of $52.63M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are David Moatazedi, See Remarks,  Vikram Malik, Director,  and Lauren Silvernail, See Remarks .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1